SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
NAT and Viral Safety In Blood Transfusion
1 references·10 citing·23 second hop
NAT and Viral Safety In Blood Transfusion (2000)NAT and Viral Safety In Blood TransfusionThe Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…Evolution of Blood Safety in Switzerland over the Last 25 Years for HIV, HCV, HBV and Treponema pallidum (2022)Evolution of Blood Safety in …Sufficient blood, safe blood: can we have both? (2012)Sufficient blood, safe blood:…A study on optimization of plasma pool size for viral infectious markers in Indian blood donors using nucleic acid amplification testing (2012)A study on optimization of pl…Magnetic bead technology for viral RNA extraction from serum in blood bank screening (2011)Magnetic bead technology for …Improving blood donor screening by nucleic acid technology (NAT) (2010)Improving blood donor screeni…Blood donor screening with cobas s 201/cobas TaqScreen MPX under routine conditions at German Red Cross institutes (2009)Blood donor screening with co…The value of increased neopterin levels in reducing transfusion-transmitted virus infections: detection of a donation from a HBsAg positive chronic carrier by screening of neopterin in Turkish blood donors (2005)The value of increased neopte…Recent experience with human immunodeficiency virus transmission by cellular blood products in Germany: antibody screening is not sufficient to prevent transmission (2002)Recent experience with human …Advances in pretransfusion infectious disease testing: ensuring the safety of transfusion therapy (2002)Advances in pretransfusion in…[Risk of transfusional-transmitted infections]. (2002)[Risk of transfusional-transm…Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus (2008)Comparison of HIV-1 detection in plasma specimens and dried blood spots using the Roche COBAS Ampliscreen HIV-1 test in Kisumu, Kenya (2011)Nucleic acid testing: Is it the only answer for safe Blood in India? (2016)The Brazilian experience of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in blood donors (2018)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Impact of grey zone sample testing by enzyme-linked immunosorbent assay in enhancing blood safety: Experience at a tertiary care hospital in North India (2015)Assessing risks of infection with herpes viruses during transfusion of donor blood and its components (2020)HIV, HBV and HCV: New Developments Related to Transfusion Safety (2000)HIV, HBV and HCV: new developments related to transfusion safety. (2000)Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases (2000)Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study (1995)Paying for blood donations: still a risk? (2002)The Measurement of Observer Agreement for Categorical Data (1977)The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)Assessing Acceptability of Short Message Service Based Interventions towards Becoming Future Voluntary Blood Donors (2014)Prevalence and trends of transfusion-transmittable infections among blood donors in Southwest China (2017)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996 (2000)Current and Emerging Infectious Risks of Blood Transfusions (2003)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited

Cited by

  • 2009Blood donor screening with cobas s 201/cobas TaqScreen MPX under routine conditions at German Red Cross institutes22 cited
  • 2012Sufficient blood, safe blood: can we have both?18 cited
  • 2002[Risk of transfusional-transmitted infections].13 cited
  • 2010Improving blood donor screening by nucleic acid technology (NAT)12 cited
  • 2022Evolution of Blood Safety in Switzerland over the Last 25 Years for HIV, HCV, HBV and Treponema pallidum10 cited
  • 2012A study on optimization of plasma pool size for viral infectious markers in Indian blood donors using nucleic acid amplification testing10 cited
  • 2002Recent experience with human immunodeficiency virus transmission by cellular blood products in Germany: antibody screening is not sufficient to prevent transmission10 cited
  • 2011Magnetic bead technology for viral RNA extraction from serum in blood bank screening9 cited
  • 2005The value of increased neopterin levels in reducing transfusion-transmitted virus infections: detection of a donation from a HBsAg positive chronic carrier by screening of neopterin in Turkish blood donors8 cited
  • 2002Advances in pretransfusion infectious disease testing: ensuring the safety of transfusion therapy8 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work